Research graph
References from Progressive fibrotic interstitial lung disease emerging after pulmonary tuberculosis: a retrospective observational study. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2025 · External reference
Understanding the spectrum and management of post-tuberculosis lung disease: a comprehensive review
2024 · External reference
Charting the course in post-tuberculosis lung disease: from inflammation to intervention
10.1016/j.arbres.2025.09.017 · 2025 · External reference
Post-tuberculosis lung disease: clinical review of an under-recognised global challenge
10.1159/000512531 · 2021 · External reference
Post-tuberculosis lung disease: towards prevention, diagnosis, and care
10.1016/s2213-2600(24)00429-6 · 2025 · External reference
Pathogenesis of post-tuberculosis lung disease: defining knowledge gaps and research priorities at the second international post-tuberculosis symposium
10.1164/rccm.202402-0374so · 2024 · External reference
Scars from the pandemic: understanding post-COVID-19 interstitial lung disease
10.1183/20734735.0037-2025 · 2025 · External reference
Post COVID interstitial lung abnormalities-incidence and management
10.1007/s13665-023-00307-y · 2023 · External reference
Post-COVID-19 pulmonary fibrosis: an ongoing concern
10.4103/atm.atm_7_23 · 2023 · External reference
Post-COVID pulmonary sequelae: mechanisms and potential targets to reduce persistent fibrosis
10.1016/j.pharmthera.2025.108891 · 2025 · External reference
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
10.1164/rccm.201403-0541oc · 2014 · External reference
Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis
10.1164/rccm.201809-1650oc · 2019 · External reference
Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study
10.1513/annalsats.201308-266oc · 2014 · External reference
Evaluation of TBc identification immunochromatographic assay for rapid identification of Mycobacterium tuberculosis complex in samples from broth cultures
10.1128/jcm.01906-10 · 2011 · External reference
Unresolved reference
2013 · External reference
Interstitial lung abnormalities detected incidentally on CT: a position paper from the fleischner society
10.1016/s2213-2600(20)30168-5 · 2020 · External reference
Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias
10.1186/s12931-021-01892-9 · 2021 · External reference
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
10.1038/bmt.2012.244 · 2013 · External reference
Potential mechanisms for lung fibrosis associated with COVID-19 infection
10.1093/qjmed/hcac206 · 2023 · External reference
Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort study
10.1136/thorax-2022-219116 · 2023 · External reference
Pleuroparenchymal fibroelastosis in Mycobacterium avium complex pulmonary disease: clinical characteristics and prognostic impact
10.1183/23120541.00765-2020 · 2021 · External reference
Distinctive clinical features of radiological pleuroparenchymal fibroelastosis with nontuberculous mycobacterial pulmonary disease: a multicenter retrospective cohort study
10.1016/j.ijid.2024.107233 · 2024 · External reference
Pleuroparenchymal fibroelastosis-like lesions on chest computed tomography in routine clinical practice
10.1007/s11604-018-0805-5 · 2019 · External reference
Bilateral tuberculous pleurisy with subsequent upper lobe predominant pulmonary fibrosis mimicking pleuroparenchymal fibroelastosis
10.2169/internalmedicine.9187-17 · 2018 · External reference
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study
10.1016/j.rmed.2017.11.003 · 2017 · External reference
Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response
10.1186/s13550-020-0591-9 · 2020 · External reference
Nintedanib in progressive fibrosing interstitial lung diseases
10.1056/nejmoa1908681 · 2019 · External reference
Pleuroparenchymal fibroelastosis-like lesions on chest computed tomography in routine clinical practice
10.1007/s11604-018-0805-5 · ExternalCitation · doi-reference
Post COVID interstitial lung abnormalities-incidence and management
10.1007/s13665-023-00307-y · ExternalCitation · doi-reference
Charting the course in post-tuberculosis lung disease: from inflammation to intervention
10.1016/j.arbres.2025.09.017 · ExternalCitation · doi-reference
Distinctive clinical features of radiological pleuroparenchymal fibroelastosis with nontuberculous mycobacterial pulmonary disease: a multicenter retrospective cohort study
10.1016/j.ijid.2024.107233 · ExternalCitation · doi-reference
Post-COVID pulmonary sequelae: mechanisms and potential targets to reduce persistent fibrosis
10.1016/j.pharmthera.2025.108891 · ExternalCitation · doi-reference
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study
10.1016/j.rmed.2017.11.003 · ExternalCitation · doi-reference
Interstitial lung abnormalities detected incidentally on CT: a position paper from the fleischner society
10.1016/s2213-2600(20)30168-5 · ExternalCitation · doi-reference
Post-tuberculosis lung disease: towards prevention, diagnosis, and care
10.1016/s2213-2600(24)00429-6 · ExternalCitation · doi-reference
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
10.1038/bmt.2012.244 · ExternalCitation · doi-reference
Nintedanib in progressive fibrosing interstitial lung diseases
10.1056/nejmoa1908681 · ExternalCitation · doi-reference
Potential mechanisms for lung fibrosis associated with COVID-19 infection
10.1093/qjmed/hcac206 · ExternalCitation · doi-reference
Evaluation of TBc identification immunochromatographic assay for rapid identification of Mycobacterium tuberculosis complex in samples from broth cultures
10.1128/jcm.01906-10 · ExternalCitation · doi-reference
Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort study
10.1136/thorax-2022-219116 · ExternalCitation · doi-reference
Post-tuberculosis lung disease: clinical review of an under-recognised global challenge
10.1159/000512531 · ExternalCitation · doi-reference
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
10.1164/rccm.201403-0541oc · ExternalCitation · doi-reference
Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis
10.1164/rccm.201809-1650oc · ExternalCitation · doi-reference
Pathogenesis of post-tuberculosis lung disease: defining knowledge gaps and research priorities at the second international post-tuberculosis symposium
10.1164/rccm.202402-0374so · ExternalCitation · doi-reference
Scars from the pandemic: understanding post-COVID-19 interstitial lung disease
10.1183/20734735.0037-2025 · ExternalCitation · doi-reference
Pleuroparenchymal fibroelastosis in Mycobacterium avium complex pulmonary disease: clinical characteristics and prognostic impact
10.1183/23120541.00765-2020 · ExternalCitation · doi-reference
Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias
10.1186/s12931-021-01892-9 · ExternalCitation · doi-reference
Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response
10.1186/s13550-020-0591-9 · ExternalCitation · doi-reference
Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study
10.1513/annalsats.201308-266oc · ExternalCitation · doi-reference
Bilateral tuberculous pleurisy with subsequent upper lobe predominant pulmonary fibrosis mimicking pleuroparenchymal fibroelastosis
10.2169/internalmedicine.9187-17 · ExternalCitation · doi-reference
Post-COVID-19 pulmonary fibrosis: an ongoing concern
10.4103/atm.atm_7_23 · ExternalCitation · doi-reference
